NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

GE HealthCare Beats Q2 Estimates on Record Orders, Weighs Sale of Struggling Patient Care Unit

GE HealthCare posts record 11.1% order growth and $5.3B revenue in Q2 2026, beating estimates. Stock jumps as it reviews Patient Care unit sale.

GE HealthCare Beats Q2 Estimates on Record Orders, Weighs Sale of Struggling Patient Care Unit
Credit: Getty Images
Already have an account? Sign in.
Featured/ 07/29/2026 · 12:25 PM
GEHC
/ Don’t stop at just one post.

Related↓

Lantheus’ piflufolastat F18 (PYLARIFY in U.S. market)
09/24/2025 · 2:29 PM

New Partnership Brings Leading Prostate Cancer Detection Tool to Japan

Lantheus licenses PYLARIFY, a leading PSMA PET imaging agent for prostate cancer, exclusively to GE HealthCare for development, manufacturing, and sales in Japan, a key international market.

/ Subscriber only
/ Read more

Feed↓

Xos Wins First U.S. Air Force Contract, Enters Defense Market
08/17/2026 · 5:18 PM

Xos Wins First U.S. Air Force Contract, Enters Defense Market

Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.

/ Subscriber only
Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline
08/17/2026 · 4:49 PM

Amylyx to Reveal Phase 3 LUCIDITY Results for Avexitide Tomorrow – Stock Jumps on Clear Timeline

Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.

/ Subscriber only
EyePoint Trial Failure Seen as Positive for 4D Molecular’s 4D-150
Featured/ 08/17/2026 · 3:25 PM

B. Riley Keeps Buy on 4D Molecular After EyePoint’s Phase 3 Miss

4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe